Company Filing History:
1 out of 15 
1 out of 4 Years Active: 2012
Title: The Innovative Contributions of Maier Lorizate Nogales
Introduction
Maier Lorizate Nogales is a notable inventor based in Vizcaya, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents against retroviral infections. His work focuses on innovative solutions to combat the human immunodeficiency virus (HIV).
Latest Patents
Maier Lorizate Nogales holds a patent for "Non-proteolysable oligopeptides that inhibit glycoprotein GP41 of the AIDS virus." This invention pertains to the identification of oligopeptides, especially hexapeptides, that inhibit the binding of retroviruses to target cells. The D-hexapeptides identified in this patent provide novel therapeutic options for treating HIV infections, particularly HIV-1.
Career Highlights
Throughout his career, Maier has worked with prestigious institutions such as the University of the Basque Country and the University of Valencia. His research has contributed to the understanding and potential treatment of HIV, showcasing his commitment to advancing medical science.
Collaborations
Maier has collaborated with esteemed colleagues, including Jose Luis Nieva Escandon and Maria Jose Gomara Elena. These partnerships have enhanced his research efforts and broadened the impact of his inventions.
Conclusion
Maier Lorizate Nogales exemplifies the spirit of innovation in the field of biotechnology. His work on oligopeptides represents a significant advancement in the fight against HIV, highlighting the importance of research and collaboration in developing effective therapies.